Aerie Pharmaceuticals Logo

Pipeline

Aerie Pharmaceuticals is building a global pipeline of products and product candidates, comprising drugs and drug delivery systems, focused initially on glaucoma and retinal diseases.

 

Global Pipeline

ROCKi = Rho kinase inhibitor
PGA = Prostaglandin analog
RVO = Retinal vein occlusion

DME = Diabetic macular edema
PKCi = Protein kinase C inhibitor
wAMD = Wet age-related macular degeneration

JAKi = Janus kinase inhibitor
IKKi = I kappa kinase inhibitor
IKKbi = I kappa kinase beta inhibitor

wAMD = Wet age-related macular degeneration
GA = Geographic atrophy;
MGD = Meibomian gland disease

FDC = Fixed dose combination
DR = Diabetic retinopathy
*Filing

Rhopressa® and Rocklatan® have not been approved by any regulatory authority other than the U.S. Food and Drug Administration (FDA). Other product candidates have not been approved by the FDA or any regulatory agency.

TOP